ISB News

Beyond the Scale: How Multiomics and Biological BMI Can Help Achieve Optimal Health

In the mid-1800s, a Belgian mathematician developed what would eventually become the body mass index (BMI). This equation – calculated by dividing a person’s weight in kilograms by height in meters squared – has been an informative tool to determine if an individual is underweight, normal weight, overweight or obese. However, classical BMI is known to misclassify one-third of the population. 

ISB researchers have constructed a biological BMI that provides a more accurate representation of metabolic health and is more varied, informative and actionable than long-used classical BMI. 

ISB Senior Research Scientist Dr. Noa Rappaport, senior author of the biological BMI research that was recently published in Nature Medicine, talked about biological BMI in an ISB Research Roundtable presentation titled “Beyond the Scale: How Multiomics and Biological BMI Can Help Achieve Optimal Health.” You can watch her presentation here, or by clicking play on the video above. You can learn more about biological BMI by reading our ISB news story.

Research Roundtable

ISB hosts several Research Roundtable conversations each year to feature our leading scientists discussing their latest research. These free virtual events are designed for non-scientists, and are open to anyone interested in the topics.

Past Research Roundtable topics include complex bacterial communities, the gut microbiome, long COVID, the impact of COVID-19 on pregnancy, Alzheimer’s disease, finding drugs to treat tuberculosis, identifying markers for cancer years before diagnosis, and many more. 

You can explore all past Research Roundtable talks and our other events here.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.